Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors

Taiji Goto, Akiko Shiina, Takeshi Murata, Masato Tomii, Takanori Yamazaki, Ken Ichi Yoshida, Toshiharu Yoshino, Osamu Suzuki, Yoshitaka Sogawa, Kiyoshi Mizukami, Nana Takagi, Tomomi Yoshitomi, Maki Etori, Hiroshi Tsuchida, Tsuyoshi Mikkaichi, Naoki Nakao, Mizuki Takahashi, Hisashi Takahashi, Shigeki Sasaki

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A PDE4B subtype selective inhibitor is expected to have a wider therapeutic window than non-selective PDE4 inhibitors. In this Letter, two series of 7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives and 5,5-dioxo-7,8- dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives were evaluated for their PDE4B subtype selectivity using human PDE4B2 and PDE4D2 full length enzymes. To improve their PDE4B selectivity over PDE4D, we optimized the substituents on the pyrimidine ring and the side chain phenyl ring, resulting in several derivatives with more than 100-fold selectivity for PDE4B. Consequently, we identified 2-(3-chloro-4-methoxy-phenyl)-5,5-dioxo-7,8-dihydro-6H-thiopyrano[3, 2-d]pyrimidine derivative 54 as a highly selective PDE4B inhibitor, which had potent hPDE4B inhibitory activity with an IC50 value of 3.0 nM and 433-fold PDE4B selectivity over PDE4D.

Original languageEnglish
Pages (from-to)893-899
Number of pages7
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number3
DOIs
Publication statusPublished - Feb 1 2014

Fingerprint

Derivatives
Phosphodiesterase 4 Inhibitors
Inhibitory Concentration 50
pyrimidine
Enzymes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors. / Goto, Taiji; Shiina, Akiko; Murata, Takeshi; Tomii, Masato; Yamazaki, Takanori; Yoshida, Ken Ichi; Yoshino, Toshiharu; Suzuki, Osamu; Sogawa, Yoshitaka; Mizukami, Kiyoshi; Takagi, Nana; Yoshitomi, Tomomi; Etori, Maki; Tsuchida, Hiroshi; Mikkaichi, Tsuyoshi; Nakao, Naoki; Takahashi, Mizuki; Takahashi, Hisashi; Sasaki, Shigeki.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 24, No. 3, 01.02.2014, p. 893-899.

Research output: Contribution to journalArticle

Goto, T, Shiina, A, Murata, T, Tomii, M, Yamazaki, T, Yoshida, KI, Yoshino, T, Suzuki, O, Sogawa, Y, Mizukami, K, Takagi, N, Yoshitomi, T, Etori, M, Tsuchida, H, Mikkaichi, T, Nakao, N, Takahashi, M, Takahashi, H & Sasaki, S 2014, 'Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors', Bioorganic and Medicinal Chemistry Letters, vol. 24, no. 3, pp. 893-899. https://doi.org/10.1016/j.bmcl.2013.12.076
Goto, Taiji ; Shiina, Akiko ; Murata, Takeshi ; Tomii, Masato ; Yamazaki, Takanori ; Yoshida, Ken Ichi ; Yoshino, Toshiharu ; Suzuki, Osamu ; Sogawa, Yoshitaka ; Mizukami, Kiyoshi ; Takagi, Nana ; Yoshitomi, Tomomi ; Etori, Maki ; Tsuchida, Hiroshi ; Mikkaichi, Tsuyoshi ; Nakao, Naoki ; Takahashi, Mizuki ; Takahashi, Hisashi ; Sasaki, Shigeki. / Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors. In: Bioorganic and Medicinal Chemistry Letters. 2014 ; Vol. 24, No. 3. pp. 893-899.
@article{95b04384edde41468245cd980c301b31,
title = "Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors",
abstract = "A PDE4B subtype selective inhibitor is expected to have a wider therapeutic window than non-selective PDE4 inhibitors. In this Letter, two series of 7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives and 5,5-dioxo-7,8- dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives were evaluated for their PDE4B subtype selectivity using human PDE4B2 and PDE4D2 full length enzymes. To improve their PDE4B selectivity over PDE4D, we optimized the substituents on the pyrimidine ring and the side chain phenyl ring, resulting in several derivatives with more than 100-fold selectivity for PDE4B. Consequently, we identified 2-(3-chloro-4-methoxy-phenyl)-5,5-dioxo-7,8-dihydro-6H-thiopyrano[3, 2-d]pyrimidine derivative 54 as a highly selective PDE4B inhibitor, which had potent hPDE4B inhibitory activity with an IC50 value of 3.0 nM and 433-fold PDE4B selectivity over PDE4D.",
author = "Taiji Goto and Akiko Shiina and Takeshi Murata and Masato Tomii and Takanori Yamazaki and Yoshida, {Ken Ichi} and Toshiharu Yoshino and Osamu Suzuki and Yoshitaka Sogawa and Kiyoshi Mizukami and Nana Takagi and Tomomi Yoshitomi and Maki Etori and Hiroshi Tsuchida and Tsuyoshi Mikkaichi and Naoki Nakao and Mizuki Takahashi and Hisashi Takahashi and Shigeki Sasaki",
year = "2014",
month = "2",
day = "1",
doi = "10.1016/j.bmcl.2013.12.076",
language = "English",
volume = "24",
pages = "893--899",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors

AU - Goto, Taiji

AU - Shiina, Akiko

AU - Murata, Takeshi

AU - Tomii, Masato

AU - Yamazaki, Takanori

AU - Yoshida, Ken Ichi

AU - Yoshino, Toshiharu

AU - Suzuki, Osamu

AU - Sogawa, Yoshitaka

AU - Mizukami, Kiyoshi

AU - Takagi, Nana

AU - Yoshitomi, Tomomi

AU - Etori, Maki

AU - Tsuchida, Hiroshi

AU - Mikkaichi, Tsuyoshi

AU - Nakao, Naoki

AU - Takahashi, Mizuki

AU - Takahashi, Hisashi

AU - Sasaki, Shigeki

PY - 2014/2/1

Y1 - 2014/2/1

N2 - A PDE4B subtype selective inhibitor is expected to have a wider therapeutic window than non-selective PDE4 inhibitors. In this Letter, two series of 7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives and 5,5-dioxo-7,8- dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives were evaluated for their PDE4B subtype selectivity using human PDE4B2 and PDE4D2 full length enzymes. To improve their PDE4B selectivity over PDE4D, we optimized the substituents on the pyrimidine ring and the side chain phenyl ring, resulting in several derivatives with more than 100-fold selectivity for PDE4B. Consequently, we identified 2-(3-chloro-4-methoxy-phenyl)-5,5-dioxo-7,8-dihydro-6H-thiopyrano[3, 2-d]pyrimidine derivative 54 as a highly selective PDE4B inhibitor, which had potent hPDE4B inhibitory activity with an IC50 value of 3.0 nM and 433-fold PDE4B selectivity over PDE4D.

AB - A PDE4B subtype selective inhibitor is expected to have a wider therapeutic window than non-selective PDE4 inhibitors. In this Letter, two series of 7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives and 5,5-dioxo-7,8- dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives were evaluated for their PDE4B subtype selectivity using human PDE4B2 and PDE4D2 full length enzymes. To improve their PDE4B selectivity over PDE4D, we optimized the substituents on the pyrimidine ring and the side chain phenyl ring, resulting in several derivatives with more than 100-fold selectivity for PDE4B. Consequently, we identified 2-(3-chloro-4-methoxy-phenyl)-5,5-dioxo-7,8-dihydro-6H-thiopyrano[3, 2-d]pyrimidine derivative 54 as a highly selective PDE4B inhibitor, which had potent hPDE4B inhibitory activity with an IC50 value of 3.0 nM and 433-fold PDE4B selectivity over PDE4D.

UR - http://www.scopus.com/inward/record.url?scp=84893659559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893659559&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2013.12.076

DO - 10.1016/j.bmcl.2013.12.076

M3 - Article

C2 - 24412069

AN - SCOPUS:84893659559

VL - 24

SP - 893

EP - 899

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 3

ER -